Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: BMcV who wrote (2421)	4/19/1999 9:54:00 AM
From: wolfdog2	Read Replies (2) \| Respond to of 10280

Unfortunately, it didn't take overall market weakness to bomb the stock. Looks like my prediction of giving up the lion's share of the run from 50 to 60 is on target. I think the main problem with the stock is the shift in focus from growth type stocks (I add the qualifier since SEPR at the moment has no earnings to grow) to value stocks. In order to buy value stocks, money managers will have to sell something and it looks like SEPR is a prime sell candidate at this point.